You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
RECOMBINANT RETROVIRUS FOR SCREENING OF ANTI-AIDS DRUGS
SBC: Transgenic Sciences Inc. Topic: N/AAIDS IS A FATAL DISEASE CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS (HIV). DURING THE LIFE CYCLE OF HIV, ITS REVERSE TRANSCRIPTASE IS AN ESSENTIAL ENZYME REQUIRED FOR ITS REPLICATION. THEREFORE, IT IS AN EXCELLENT TARGET FOR ANTI-HIV THERAPEUTICS. EXTENSIVE EFFORT HAS FOCUSED ON SEARCHING FOR ITS INHIBITORS, BUT THIS HAS BEEN HINDERED BECAUSE HIV IS DANGEROUS TO HANDLE AND EXPENSIVE TO PRODUCE. THIS RE ...
SBIR Phase I 1990 Department of Health and Human Services -
CONTROL CELL LINES FOR USE IN MOLECULAR DIAGNOSTIC TESTS
SBC: Oncore Analytics Inc Topic: N/ATHE SPECIFIC AIM IS TO DEVELOP HUMAN CELL LINES CONTAINING SPECIFIC, CLONED GENES OF THE PATHOGENIC VIRUS, HIV, THE CAUSATIVE AGENT OF AIDS. EACH CELL LINE WILL CONTAIN ONLY ONE INDIVIDUAL GENE OF HIV, EXPRESSED BY A EUKARYOTIC GENE PROMOTER. THESE CELL LINES WILL PROVIDE A NONINFECTIOUS, POSITIVE CONTROL STANDARD FOR SUCH DIAGNOSTIC MOLECULAR TESTS AS SOUTHERN ANALYSIS, NORTHERN ANALYSIS, IN SITU ...
SBIR Phase I 1990 Department of Health and Human Services -
MODIFIED SURFACES FOR CHEMICALLY DEFINED CELL CULTURE
SBC: Mattek Corporation Topic: N/ATHE PRIMARY GOAL OF THIS RESEARCH IS THE DEVELOPMENT OF NOVEL PLASTICS ON WHICH TO CULTURE CELLS IN SERUM-FREE MEDIA. CURRENTLY, BIOLOGICAL ATTACHMENT AIDS MUST BE USED FOR ANCHORAGE-DEPENDENT CELLS TO ATTACH AND GROW NORMALLY INTHE ABSENCE OF SERUM. LOW-TEMPERATURE GAS PLASMA TECHNIQUES WILL BE EMPLOYED TO MODIFY THE SURFACES OF POLYSTYRENE CULTUREWARE. SUCCESS WILL BE DETERMINED BY THE ABILITY O ...
SBIR Phase I 1990 Department of Health and Human Services -
1% DAPSONE TOPICAL GEL FOR DERMATITIS HERPETIFORMIS
SBC: Virotex Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services